Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer.

Veneris, Jennifer Taylor; Huang, Lei; Churpek, Jane E; Conzen, Suzanne D; Fleming, Gini F

Veneris, Jennifer Taylor; Huang, Lei; Churpek, Jane E; Conzen, Suzanne D; Fleming, Gini F.

Afiliación

Veneris JT; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA Jennifer_Veneris@dfci.harvard.edu.
Huang L; Center for Research Informatics, The University of Chicago, Chicago, Illinois, USA.
Churpek JE; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA.
Conzen SD; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.
Fleming GF; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA.

Int J Gynecol Cancer ; 29(2): 357-364, 2019 Feb.

Article en En | MEDLINE | ID: mdl-30683758

Palabras clave

BRCA mutations; Epithelial ovarian cancer; apoptosis; glucocorticoid receptor; hormone receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google